| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.073 | 0.6 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.6 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.034 | 0.6 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.6 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.6 |